611 W. Union Street
Benson, AZ 85602
(520) 586-0800

member support line
M-F 5pm-8pm
24/7 weekends/holidays

AzCH Nurse Assist Line


611 W. Union Street
Benson, AZ 85602
(520) 586-0800

AzCH Nurse Assist Line


powered by centersite dot net
Medical Disorders
Basic InformationLookupsLatest News
Many U.S. Seniors May Need Better Knee Arthritis CareAfter COVID, Many Americans Are Struck by New Maladies: StudyCataracts: Common, and Easy to TreatThere Are Many Good Reasons for Kids to Get the COVID VaccineBabies Produce Strong Immune Response to Ward Off COVID-19: StudyNovavax's COVID Vaccine Shines in Latest TrialAHA News: U.S. Appears to Lose Ground in Controlling High Blood PressureOdds for Death, Hospital Care Rise When Statins Are StoppedWeight-Loss Surgeries Used Least in U.S. States That Need Them MostObesity Could Raise Odds for 'Long-Haul' COVID SymptomsSmokers, Obese People Need Major Heart Interventions Earlier in LifeOld Age No Bar to Successful Heart Transplant, Study FindsCOVID Antibody Treatment Is Safe, Effective in Transplant PatientsThere Is No 'Healthy Obesity,' Study FindsExpiration Dates on Johnson & Johnson COVID Vaccine ExtendedWill People Really Need a Yearly COVID Booster Vaccine?America Is Losing the War Against DiabetesGene Editing Technique Corrects Sickle Cell Disease in MiceCOVID Vaccines Appear Safe for People With IBDNew Treatment Fights Rare Cases of Vaccine-Linked Blood ClotsWoman Dies From Dengue Fever Acquired in FloridaAstraZeneca COVID Vaccine Tied to Rare Cases of Low Blood PlateletsWhy a COVID Diagnosis Could Cost You Way More Money in 2021New Links Between Poor Sleep, Diabetes and DeathVaccinations More Urgent as Variant That Crippled India Shows Up in the U.S.Think You Can Skip That Annual Physical?  Think AgainReal-World Study Shows Power of Pfizer, Moderna Vaccines to Prevent COVIDDeath Rates Are Rising Across Rural AmericaWhat Diet Is Most Likely to Help Ease Crohn's Disease?'Breakthrough' COVID Infections May Be Common in Vaccinated Transplant PatientsYour Teen's Smartphone Could Be Key to Unhealthy WeightToo Much Caffeine Might Raise Your Odds for GlaucomaPeople of Color Have Twice the Risk of Dying After Brain Injury, Study FindsStudy Pinpoints Cancer Patients at Highest Risk From COVIDMany Existing Drugs Could Be Potent COVID Fighters: StudyAntibiotics Won't Help Fight Lung-Scarring Disease IDF: StudyNew Disabilities Plague Half of COVID Survivors After Hospital DischargeDeclining Vaccination Rates Threaten Biden's July 4 GoalYour Doctor Appointments Might Look Different Post-PandemicPrior COVID Infection May Shield You From Another for at Least 10 MonthsTeens: You Got Your COVID Vaccine, What Now?White House Lists Countries Getting First Batch of Extra COVID VaccinesStrokes Hitting COVID Patients Are More Severe: StudyAverage COVID Hospital Bill for U.S. Seniors Nearly $22,000Deep Brain Stimulation Therapy May Help Parkinson's Patients Long TermNIH Starts Trial Assessing 'Mix & Match' COVID Vaccine ApproachAllergy Treatment Crucial If Your Child Has AsthmaScientists Discover Rare Form of ALS That Can Strike KidsGlobal Warming to Blame for 1 in 3 Heat-Related Deaths WorldwideBlood Sugar Tests Using Sweat, Not Blood? They Could Be on the Way
Questions and AnswersLinksBook Reviews
Related Topics

Men's Health
Women's Health

Could a Vaccine Against Future Pandemics Be on the Way?

HealthDay News
by By Alan Mozes HealthDay Reporter
Updated: May 12th 2021

new article illustration

WEDNESDAY, May 12, 2021 (HealthDay News) -- An ambitious new vaccine effort is taking aim at future coronavirus mutations that may threaten global health down the road.

So far, the "pan-coronavirus vaccine" has proven 100% effective in testing among monkeys, investigators reported.

"Large outbreaks of coronaviruses have occurred three times in the last 18 years," explained study author Kevin Saunders, director of research at the Duke University Human Vaccine Institute in Durham, N.C. "They tend to occur about every eight to nine years."

And new virus mutations are almost certainly already out there, lying in wait for a chance to jump from animals to people.

They "can be found in wild animals … where coronaviruses that cause outbreaks circulate, until they have an opportunity to transmit to humans," Saunders noted. "Thus, we need a vaccine not only to end the current pandemic, but to also prevent future pandemics.

"Current vaccine platforms are targeted to blocking the virus that causes COVID-19," he noted. "A pan-coronavirus vaccine would block many different coronaviruses," and in doing so "protect you against the coronavirus that is causing the current pandemic, but also future related coronaviruses."

With that in mind, the new vaccine effort centers on what the study team calls the "Achilles' heel" of a coronavirus: a particular spot on the spiky surface of the virus that needs to bind with human cells to infect them.

The good news, said researchers, is that this spot is a vulnerable target, regardless of which particular version of the coronavirus is in play. In other words, it may be possible to block a wide variety of current and future coronavirus variants.

To that end, the Duke team fashioned a high-tech molecular weapon, composed of a tiny nanoparticle paired with a specific receptor blocker (called 3M-052). The molecular architecture of the pairing essentially takes a small piece of the existing coronavirus structure and generates multiple copies of it to shield human cells from coronavirus spikes.

The result: In monkeys, the pan-vaccine appeared to boost the immune response more robustly than either current vaccines or a natural coronavirus infection.

In fact, it blocked all infections without fail, regardless of whether the infection source was the so-called original human coronavirus (SARS-CoV-1) or any of the four most common mutations of the later viral iteration (SARS-CoV-2, which causes COVID-19), including variants widely referred to as having first been spotted in the United Kingdom, South Africa and Brazil.

So far, the pan-vaccine has also proved 100% effective at halting infections involving animal coronaviruses that have not yet crossed over to humans.

"The results in primate model systems of COVID-19 shows the vaccine can completely suppress the virus that causes COVID-19," Saunders said.

Still, the immune response seen in monkeys can sometimes end up being less potent in humans, the team acknowledged. So Saunders and his associates stressed that clinical trials in humans will be needed "in order to know what level of response humans will have to the vaccine."

In addition, "we are exploring ways to broaden the activity of the vaccine such that it covers as many coronaviruses as possible," Saunders said. "We are also exploring ways to combine the current vaccine with rapid vaccine manufacturing processes already in use."

All these efforts sound like a good plan to Dr. Amesh Adalja, a senior scholar with the Johns Hopkins Center for Health Security in Baltimore.

"Within the coronavirus family, there are several that have the ability to infect humans and some -- MERS, SARS, SARS2 -- that can cause serious disease," Adalja noted.

"Having a vaccine that targets more than one coronavirus can help remove them as a threat," he said. "There are definitely more coronaviruses that will emerge and have the ability to infect humans. So, this would be a proactive action to preempt [future] emergence."

The latest findings were published May 10 in the journal Nature.

More information

There's more on various types of coronavirus vaccines at the U.S. Centers for Disease Control and Prevention.

SOURCES: Kevin Saunders, PhD, director, research, Duke Human Vaccine Institute, Duke University, Durham, N.C.; Amesh Adalja, MD, senior scholar, Johns Hopkins Center for Health Security, Baltimore; Nature, May 10, 2021